CureVac N.V.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CureVac N.V. generated cash of -$267,887,000, which is more than the previous year. Cash used in financing activities reached the amount of $230,893,000 last year. Net change in cash is therefore -$93,345,000.
Cash Flow
| 2018 | -74.11M | -4.26M | -112K |
|---|---|---|---|
| 2019 | -86.96M | 28.18M | 67.97M |
| 2020 | 522.40M | -45.27M | 819.83M |
| 2021 | -733.12M | -127.90M | 344.96M |
| 2022 | -286.17M | -93.49M | 63.17M |
| 2023 | -267.88M | -55.2M | 230.89M |
CVAC Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 495.79M | 811.46M | 1.32B | 30.68M | 21.38M | 99.65M |
Operating activities | ||||||
Net income | -260.16M | -249.15M | -412.49M | -129.84M | -100.12M | -71.13M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 23.38M | 23.74M | 15.67M | 10.67M | 7.16M | 3.78M |
Stock-based compensation expense | 7.69M | 9.18M | 14.95M | 14.24M | 19.56M | 0 |
| Deferred income tax benefit | 7.69M | 9.18M | 14.95M | 14.24M | 19.56M | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -7.91M | -16.68M | -19.82M | -32.30M | -10.11M | -5.59M |
Inventories | -46.95M | -47.85M | -227.46M | -8.33M | -3.24M | 878K |
Accounts payable | -29.36M | -96.18M | 179.31M | 620.30M | -9.58M | 9.40M |
Cash generated by operating activities | -267.88M | -286.17M | -733.12M | 522.40M | -86.96M | -74.11M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | -1.16M | 0 | 0 |
Investments In Property Plant And Equipment | -52.32M | -93.22M | -127.90M | -47.35M | -12.22M | -14.72M |
Acquisitions Net | 0 | -277K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -55.2M | -93.49M | -127.90M | -45.27M | 28.18M | -4.26M |
Financing activities | ||||||
Common Stock Issued | 236.08M | 67.39M | 404.06M | 867.71M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -34.10M | 0 | 0 | 0 |
Repayments of term debt | -5.19M | -4.22M | -28.18M | -97.74M | 67.97M | -112K |
Cash used in financing activities | 230.89M | 63.17M | 344.96M | 819.83M | 67.97M | -112K |
Net Change In Cash | -93.34M | -315.66M | -511.12M | 1.29B | 9.30M | -78.27M |
Cash at end of period | 402.45M | 495.79M | 811.46M | 1.32B | 30.68M | 21.38M |
| Data source | Data source | Data source | Data source |